Q9NHV9
Gene name |
Vav (CG7893) |
Protein name |
Protein vav |
Names |
DroVav, dVAV |
Species |
Drosophila melanogaster (Fruit fly) |
KEGG Pathway |
dme:Dmel_CG7893 |
EC number |
|
Protein Class |
|

Descriptions
The Vav family is a group of tyrosine phosphorylation-dependent guanine nucleotide exchange factors (GEFs) that activate members of the Rac and Rho families of guanosine triphosphatases (GTPases) downstream of protein tyrosine kinases. In mouse Vav1, When the tyrosine residues within the Ac region are non-phosphorylated, the CH domain and Ac region occlude the GTPase-binding site within DH domain. The interaction is stabilized by the interaction between the hydroxyl group of Tyr174 within Ac region and GTPase binding site as well as the interaction between CH domain and DH-PH domains. The Y174F mutant displays constitutive and phosphorylation-independent catalytic activity. In addition to the N-terminal autoinhibitory regions, the truncation of C-terminal SH3 domain also relives the autoinhibition. C-terminal SH3 domain interacts with DH-PH domains and the intramolecular interaction occludes the GTPase-binding site of DH domain. In Drosophila, only the involvement of SH3 domain in autoinhibition has been experimentally identified.
Autoinhibitory domains (AIDs)
Target domain |
216-396 (DH domain) |
Relief mechanism |
PTM |
Assay |
|
Target domain |
216-396 (DH domain) |
Relief mechanism |
PTM |
Assay |
|
Target domain |
216-396 (DH domain) |
Relief mechanism |
Partner binding, PTM |
Assay |
|
Accessory elements
No accessory elements
Autoinhibited structure

Activated structure

1 structures for Q9NHV9
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
AF-Q9NHV9-F1 | Predicted | AlphaFoldDB |
No variants for Q9NHV9
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
No variants for Q9NHV9 |
No associated diseases with Q9NHV9
No regional properties for Q9NHV9
Type | Name | Position | InterPro Accession |
---|---|---|---|
No domain, repeats, and functional sites for Q9NHV9 |
2 GO annotations of cellular component
2 GO annotations of molecular function
Name | Definition |
---|---|
guanyl-nucleotide exchange factor activity | Stimulates the exchange of GDP to GTP on a signaling GTPase, changing its conformation to its active form. Guanine nucleotide exchange factors (GEFs) act by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP), which is more abundant in the cell under normal cellular physiological conditions. |
metal ion binding | Binding to a metal ion. |
21 GO annotations of biological process
Name | Definition |
---|---|
actin cytoskeleton reorganization | A process that is carried out at the cellular level which results in dynamic structural changes to the arrangement of constituent parts of cytoskeletal structures comprising actin filaments and their associated proteins. |
activation of GTPase activity | Any process that initiates the activity of an inactive GTPase through the replacement of GDP by GTP. |
axon guidance | The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues. |
axonogenesis | De novo generation of a long process of a neuron, including the terminal branched region. Refers to the morphogenesis or creation of shape or form of the developing axon, which carries efferent (outgoing) action potentials from the cell body towards target cells. |
border follicle cell migration | The directed movement of a border cell through the nurse cells to reach the oocyte. An example of this is found in Drosophila melanogaster. |
cell migration | The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms. |
central nervous system development | The process whose specific outcome is the progression of the central nervous system over time, from its formation to the mature structure. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain and spinal cord. In those invertebrates with a central nervous system it typically consists of a brain, cerebral ganglia and a nerve cord. |
compound eye morphogenesis | The morphogenetic process in which the anatomical structures of the compound eye are generated and organized. The adult compound eye is a precise assembly of 700-800 ommatidia. Each ommatidium is composed of 20 cells, identified by cell type and position. An example of compound eye morphogenesis is found in Drosophila melanogaster. |
dorsal closure | The process during Drosophila embryogenesis whereby the ectodermal cells of the lateral epithelium stretch in a coordinated fashion to internalize the amnioserosa cells and close the embryo dorsally. |
epidermal growth factor receptor signaling pathway | The series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
localization | Any process in which a cell, a substance, or a cellular entity, such as a protein complex or organelle, is transported, tethered to or otherwise maintained in a specific location. In the case of substances, localization may also be achieved via selective degradation. |
melanotic encapsulation of foreign target | Formation of a multilayered, melanized sheath of cells around a foreign invader. |
myoblast fusion | A process in which non-proliferating myoblasts fuse to existing fibers or to myotubes to form new fibers. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers. |
negative regulation of epidermal growth factor receptor signaling pathway | Any process that stops, prevents, or reduces the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity. |
open tracheal system development | The process whose specific outcome is the progression of an open tracheal system over time, from its formation to the mature structure. An open tracheal system is a respiratory system, a branched network of epithelial tubes that supplies oxygen to target tissues via spiracles. An example of this is found in Drosophila melanogaster. |
photoreceptor cell axon guidance | The chemotaxis process that directs the migration of a photoreceptor cell axon growth cone to its target in the optic lobe in response to a combination of attractive and repulsive cues. |
positive regulation of actin cytoskeleton reorganization | Any process that activates or increases the frequency, rate or extent of actin cytoskeleton reorganization. |
positive regulation of ERK1 and ERK2 cascade | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
regulation of adherens junction organization | Any process that modulates the frequency, rate or extent of adherens junction organization. |
regulation of GTPase activity | Any process that modulates the rate of GTP hydrolysis by a GTPase. |
vascular endothelial growth factor receptor signaling pathway | The series of molecular signals initiated by a ligand binding to a vascular endothelial growth factor receptor (VEGFR) on the surface of the target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. |
9 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
Q08DN7 | VAV1 | Proto-oncogene vav | Bos taurus (Bovine) | SS |
Q9UKW4 | VAV3 | Guanine nucleotide exchange factor VAV3 | Homo sapiens (Human) | SS |
P52735 | VAV2 | Guanine nucleotide exchange factor VAV2 | Homo sapiens (Human) | SS |
P15498 | VAV1 | Proto-oncogene vav | Homo sapiens (Human) | EV SS |
Q9R0C8 | Vav3 | Guanine nucleotide exchange factor VAV3 | Mus musculus (Mouse) | SS |
P27870 | Vav1 | Proto-oncogene vav | Mus musculus (Mouse) | EV |
Q60992 | Vav2 | Guanine nucleotide exchange factor VAV2 | Mus musculus (Mouse) | SS |
P54100 | Vav1 | Proto-oncogene vav | Rattus norvegicus (Rat) | SS |
Q45FX5 | vav-1 | Protein vav-1 | Caenorhabditis elegans | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MASSSSSNSF | GGVAGVNGDL | WRECVAWLTR | CKVIPPDHKA | AQPDAEIRIL | AMTLRDGVLL |
70 | 80 | 90 | 100 | 110 | 120 |
CNLVIHLDPS | SLDPREFNRK | PQMAQFLCSK | NIKLFLDVCH | NNFGIRDADL | FEPTMLYDLT |
130 | 140 | 150 | 160 | 170 | 180 |
NFHRVLITLS | KLSQCRKVQQ | LHPDLIGFNL | QLSPTERSHS | DEAIYKDLHS | TTTDNIACNG |
190 | 200 | 210 | 220 | 230 | 240 |
TGYDHTNTKE | EEVYQDLCAL | HRTSRSQTAS | STSFEQRDYV | IRELIDTESN | YLDVLTALKT |
250 | 260 | 270 | 280 | 290 | 300 |
KFMGPLERHL | NQDELRLIFP | RIRELVDIHT | KFLDKLRESL | TPNAKVKMAQ | VFLDFREPFL |
310 | 320 | 330 | 340 | 350 | 360 |
IYGEFCSLLL | GAIDYLADVC | KKNQIIDQLV | QKCERDYNVG | KLQLRDILSV | PMQRILKYHL |
370 | 380 | 390 | 400 | 410 | 420 |
LLDKLVKETS | PLHDDYRSLE | RAKEAMIDVS | QYINEVKRDS | DHLVIIQKVK | DSICDIHLLQ |
430 | 440 | 450 | 460 | 470 | 480 |
NGNGSDLLQY | GRLLLDGELH | IKAHEDQKTK | LRYAFVFDKI | LIMVKALHIK | TGDMQYTYRD |
490 | 500 | 510 | 520 | 530 | 540 |
SHNLADYRVE | QSHSRRTIGR | DTRFKYQLLL | ARKSGKTAFT | LYLKSEHERD | KWRKALTEAM |
550 | 560 | 570 | 580 | 590 | 600 |
ESLEPPGCQS | TDHKMEIYTF | DAPTTCRHCS | KFLKGRIHQG | YRCKVCQISV | HKGCISSTGR |
610 | 620 | 630 | 640 | 650 | 660 |
CKQNPVSVPP | PVCDRQLSEF | NWFAGNMDRE | TAAHRLENRR | IGTYLLRVRP | QGPSTAHETM |
670 | 680 | 690 | 700 | 710 | 720 |
YALSLKTDDN | VIKHMKINQE | NSGDSMLYCL | SSRRHFKTIV | ELVSYYERND | LGENFAGLNQ |
730 | 740 | 750 | 760 | 770 | 780 |
SLQWPYKEVI | ATALYDYEPK | AGSNQLQLRT | DCQVLVIGKD | GDSKGWWRGK | IGDTVGYFPK |
790 | |||||
EYVQEQKLAS | EEL |